Skip to main content
. 2020 Sep 16;22(10):1835–1845. doi: 10.1111/jch.13893

FIGURE 2.

FIGURE 2

Primary end points: MSSBP and LDL‐C changes at week 8. A, the least‐square mean values (LS Means, SE) of the MSSBP in the two (telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg and telmisartan 80 mg + rosuvastatin 20 mg) groups. B, the LS Means for LDL cholesterol reduction in the two (telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg and telmisartan/amlodipine 80/5 mg) groups